APPENDIX C 
ORDA will review the composition of institutional biohazards 
coiTimittees for compliance with the recommendations stated in the 
Guidelines, and will maintain updated lists of such complying 
committees. Serious questions about the suitability of a committee 
will be brought to the attention of the Executive Committee. 
IX. Information on Accidents, Containment and Innovations 
As stipulated by the Guidelines, investigators are required to 
report to ORDA and to their institutional biohazards committees 
any serious or extended illness of a worker, or any accidents 
of the type described in the Guidelines. The Guidelines also 
require that investigators report to ORDA and their biohazards 
coiTimittee any problems pertaining to operation and implem.entation 
of biological and physical containment safety practices and pro- 
cedures, or equipment or facility failure. 
ORDA will receive from investigators information on purported 
EK2 and EK3 systems, and information bearing on the Guidelines, 
such as technical information relating to hazards and new safety 
procedures or innovations. 
CM)A will receive and file these reports and, as appropriate, 
bring them to the attention of the Deputy Director for Science, 
NIH, the Office of Research Safety, NCI, and the Recombinant 
Advisory Committee or subcommittees therof . ORDA may, after 
review, recommend appropriate action to the Deputy Director for 
Science, NIH. 
X. Recombinant DNA Molecule Program Advisory Committee 
ORDA will have the management responsibilities for the Recom- 
binant Advisory Committee, will serve as its staff, and will 
provide the Executive Secretary. Staff functions will in- 
clude the gathering, analysis and dissemination of information, 
the presentation of issues, etc. 
XI. Transition and Implementation 
Proposals for initial gathering of information on NIH activities 
in this area and implementation of the Guidelines are discussed 
in Appendix C. 
Appendix C — 5 
